drugset / Trial / NCT01866540

Immune Response To Intranasal Influenza Vaccination

NCT01866540

NaSingle-groupOpen-labelPrevention

Summary

This research during the last decade has focused on the kinetics of the systemic and local immune response to parenteral influenza vaccine in humans. The investigators have shown that normally high numbers of influenza specific antibody secreting cells (ASC) are present in the nasal mucosa of healthy adults but upon parenteral vaccination the numbers remain stable. However, a rapid transient increase in specific ASC is observed in the tonsils and peripheral blood after parenteral vaccination. In the tonsils, this is associated with a significant decrease in both naïve/effector (CD45RA+) and memory (CD45RO+) CD4+ cells upon vaccination. In this study the investigators will extend our work to investigate the characteristics of influenza-specific T- and B-cells induced locally and systemically after intranasal vaccination in man.

Timeline

Start
2012-10-01
Primary completion
2025-12-31
Completion
2030-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject FluMist Vaccine Intranasal

Indications